Vitamin E increases the risk of developing heart failure after myocardial infarction: Results from the GISSI-Prevenzione trial

Journal of Cardiovascular Medicine
Roberto MarchioliGISSI-Prevenzione Investigators

Abstract

Although results from basic science suggested a protective role of vitamin E treatment in the prevention of cardiovascular disease, recent evidence indicates increased cardiovascular mortality due to vitamin E treatment. Recently, the HOPE trial showed an increment of the incidence of congestive heart failure (CHF) in patients treated with vitamin E. We explored the effect of vitamin E on development of CHF in 8415 postinfarction patients without CHF at baseline, with an echocardiographic measure of left ventricular ejection fraction, who have been followed up for 3.5 years in the GISSI-Prevenzione trial. CHF during follow-up was defined as hospitalization or death for CHF. Cox regression models adjusted for relevant prognostic indicators were fitted. Main clinical characteristics were balanced in the 4202 and 4213 patients allocated vitamin E and control group, respectively. During follow-up, 220 patients (2.6%) developed CHF. Patients allocated vitamin E had a nonsignificant 20% (95% confidence intervals 0.92-1.56, P = 0.18) increased risk of developing CHF. Vitamin E treatment, however, was associated with a significant 50% increase (95% confidence intervals 1.03-2.20, P = 0.034) of CHF in patients with left ventricular dysf...Continue Reading

References

Apr 14, 1994·The New England Journal of Medicine·UNKNOWN Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group
May 20, 1993·The New England Journal of Medicine·M J StampferW C Willett
Feb 12, 1998·JAMA : the Journal of the American Medical Association·E B RimmM J Stampfer
Jan 20, 2000·The New England Journal of Medicine·UNKNOWN Heart Outcomes Prevention Evaluation Study InvestigatorsP Sleight
Nov 23, 2000·Nature·T Finkel, N J Holbrook
Mar 27, 2001·Archives of Internal Medicine·R J BlendonD E Altman
Sep 27, 2001·JAMA : the Journal of the American Medical Association·W A GhaliUNKNOWN APPROACH (Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease) Investigators
Jan 5, 2002·The New England Journal of Medicine·B G BrownJ J Albers
Mar 19, 2002·Journal of the American College of Cardiology·Takashi TsutsuiMasahiko Kinoshita
Dec 23, 2003·Clinica Chimica Acta; International Journal of Clinical Chemistry·Ntei AbuduStanley S Levinson
Jan 28, 2004·Annual Review of Pharmacology and Toxicology·James E Klaunig, Lisa M Kamendulis
May 22, 2004·Public Health Nutrition·S A StannerJ Buttriss
Aug 4, 2004·Circulation·Penny M Kris-EthertonUNKNOWN Nutrition Committee of the American Heart Association Council on Nutrition, Physical Activity, and Metabolism
Nov 13, 2004·Annals of Internal Medicine·Edgar R MillerEliseo Guallar
Mar 17, 2005·JAMA : the Journal of the American Medical Association·Eva LonnUNKNOWN HOPE and HOPE-TOO Trial Investigators
Jul 7, 2005·JAMA : the Journal of the American Medical Association·I-Min LeeJulie E Buring

❮ Previous
Next ❯

Citations

Jan 4, 2012·Current Heart Failure Reports·Zain Ahmed, W H Wilson Tang
Oct 17, 2012·Current Heart Failure Reports·Selim R KrimHector Ventura
May 31, 2012·Current Treatment Options in Cardiovascular Medicine·Donald S Silverberg, Doron Schwartz
Oct 14, 2008·Genes & Nutrition·Regina Brigelius-Flohé
Oct 25, 2008·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·E M SeymourSteven F Bolling
Aug 12, 2008·American Journal of Physiology. Heart and Circulatory Physiology·S Kelly AmblerLawrence D Horwitz
Mar 23, 2012·Circulation. Heart Failure·Claudia U ChaeJulie E Buring
Aug 24, 2007·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Diane NykampAmy P Wenker
Sep 14, 2014·Heart Failure Clinics·Brent N ReedCarla A Sueta
Jul 7, 2011·Indian Journal of Clinical Biochemistry : IJCB·P P SinghPraveen Sharma
Jun 21, 2011·Heart Failure Reviews·Hong WangJian-Jun Li
Feb 24, 2016·Frontiers in Pharmacology·Valeria ContiAmelia Filippelli
Jul 13, 2011·The American Journal of the Medical Sciences·Douglas B Sawyer
Jun 20, 2012·Journal of the Academy of Nutrition and Dietetics·Nicholas A McKeagPascal P McKeown
Mar 31, 2009·Journal of Diabetes and Its Complications·Turgay CelikAtila Iyisoy
Feb 4, 2014·Oxidative Medicine and Cellular Longevity·Matilde Otero-LosadaJosé Milei
May 1, 2015·Clinical Science·Elyse Di MarcoJudy B de Haan
Nov 28, 2007·Orvosi hetilap·János FehérGabrieli Corrado Balacco
Dec 12, 2012·Journal of the American College of Cardiology·Marina BayevaHossein Ardehali
Oct 2, 2012·Nutrition·Miroslava ValentováAnja Sandek
Apr 1, 2014·Free Radical Biology & Medicine·Anna-Liisa LevonenVictor M Darley-Usmar
Feb 27, 2009·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Steven P DunnOrly Vardeny
Jan 16, 2016·Therapeutic Advances in Gastroenterology·Mary E RinellaStephen A Harrison
Dec 31, 2009·The Annals of Pharmacotherapy·Alexander L RogovikRan D Goldman
Jul 13, 2016·Circulation·Robert L PageUNKNOWN American Heart Association Clinical Pharmacology and Heart Failure and Transplantation Committees of the Council on Clinical
Jun 5, 2013·Circulation. Heart Failure·Sasiwarang Goya WannametheePeter H Whincup
Oct 2, 2008·The British Journal of Nutrition·S Honarbakhsh, M Schachter
Aug 10, 2007·Journal of the American Society of Nephrology : JASN·Anja Sachse, Gunter Wolf
Sep 7, 2007·Medicine and Science in Sports and Exercise·Karyn L Hamilton
Aug 21, 2008·Critical Reviews in Clinical Laboratory Sciences·Michael W ClarkeKevin D Croft
Mar 7, 2012·Expert Review of Cardiovascular Therapy·Christine KoulisTerri J Allen
Aug 16, 2019·European Journal of Preventive Cardiology·Alberto AimoAlberto Giannoni
Aug 23, 2019·Nutrition and Cancer·Mika D Thompson, Robert V Cooney
Sep 29, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Hiroyuki TsutsuiShouji Matsushima
Oct 7, 2017·Cardiology in Review·Sulaiman SultanArshad Jahangir
Jan 25, 2020·Journal of Occupational and Environmental Medicine·Kurt T HegmannJeffrey S Harris
Mar 17, 2020·Nutrition Research Reviews·Arrigo F G CiceroUNKNOWN International Lipid Expert Panel
Nov 21, 2014·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Savita KhannaCameron Rink
May 2, 2018·Clinical & Translational Immunology·Raelene J PickeringJudy B de Haan
Nov 9, 2018·Frontiers in Pharmacology·Bee Ling TanHeshu Sulaiman Rahman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.